Compare Franklin FTSE South Korea ETF (FLKR) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $49.84 (market cap $1.67B), while GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 18.5× Franklin FTSE South Korea ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Franklin FTSE South Korea ETF pays none. Which is the better fit depends on your goals.
| FLKR | GEHC | |
|---|---|---|
Market Cap | $1.67B | $30.93B |
Volume | 880,778 | 5,033,451 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $88.16 |
52-Week Low | $28.48 | $59.48 |
Typical Hold Time | 15 Days | — |
Enterprise Value | — | $39.39B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLKR (Franklin FTSE South Korea ETF) is trading at $54.89, down 2.03% with a bearish technical signal (16 sell vs 6 buy signals). The ETF faces pressure from semiconductor sector volatility and rising global yields, though some analysts see current levels as a potential buying opportunity. Technical indicators show strong resistance at $55-$56 with support at $53-$54 levels. The fund remains heavily concentrated in Korean memory chip giants Samsung and SK Hynix, making it highly sensitive to AI and semiconductor cycles.
While FLKR faces near-term headwinds from semiconductor volatility and macroeconomic pressures, long-term prospects remain tied to AI-driven demand for Korean tech. The current discount to growth expectations presents opportunity, but investors must weigh concentration risk against potential semiconductor recovery. Key risks include political tensions, currency fluctuations, and global interest rate environment.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
